Specifically, tumor stage (HR, 1.595; P<0.001), T stage (HR, 1.618; P<0.001), N stage (HR, 1.732; P<0.001) and risk score (HR, 1.517; P<0.001) were significantly associated with prognosis, and M stage (HR, 1.858; P=0.034) was marginally significant ( Fig. 6A ).
← all excerpts
Development of a coagulation‑related gene model for prognostication, immune response and treatment prediction in lung adenocarcinoma.
1
—
—